The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1
Abstract
Two isozymes of 11beta-hydroxysteroid dehydrogenase (11betaHSD) catalyze the interconversion of hormonally active cortisol to inactive cortisone. Activity and messenger ribonucleic acid studies indicate that type 1 11betaHSD (11betaHSD1) is expressed in glucocorticoid target tissues such as liver, gonad, and cerebellum, where it regulates the exposure of cortisol to glucocorticoid receptors. To further understand the role of 11betaHSD1 in human tissues, we have studied the localization of this isozyme using an antibody raised in sheep against amino acids 19-33 of human 11betaHSD1. Western blot analyses indicated that the immunopurified antibody recognized a band of approximately 34 kDa in human liver and decidua. Immunoperoxidase studies on liver, adrenal, ovary, decidua, and adipose tissue indicated positive cytoplasmic staining for 11betaHSD1. 11BetaHSD1 immunoreactivity was observed more intensely around the hepatic central vein, with no staining around the portal vein, hepatic artery, or bile ducts. No staining for 11betaHSD1 was observed in the adrenal medulla, but 11betaHSD1-immunoreactive protein was observed in all three zones of the adrenal cortex, with the most intense staining in the zona reticularis > zona glomerulosa > zona fasciculata. In the human ovary, immunoreactivity was observed in the developing oocyte and the luteinized granulosa cells of the corpus luteum. No staining was observed in granulosa cells, thecal cells, or ovarian stroma, which contrasted with the marked expression of 11betaHSD2 in the granulosa cell layer. Sections of human decidua showed high expression of 11betaHSD1 in decidual cells. In omental adipose tissue, 11betaHSD1 immunoreactivity was observed in both stromal and adipocyte cells. Immunohistochemical localization of 11betaHSD1 in human liver, adrenal, ovary, decidua, and adipose tissue using this novel antiserum provides us with a tool to investigate the role of this isozyme in modulating glucocorticoid hormone action within these tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628 · cited 1×
“Although 11bHSD1 was the first enzyme to be characterized and cloned in rodent and human tissues (1, 13), there has been recent interest in the 11bHSD2 isozyme (2), principally because of its role in protecting the mineralocorticoid receptor from cortisol excess (14, 15) and its association with human hypertension (7–…”
BackgroundDoes central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753 · cited 1×
“Immunolocalization of 11bHSD1 within omental adipose tissue is in keeping with our recent mRNA/activity studies in which we suggested that this isozyme may play a pivotal role in regulating glucocorticoid-mediated adipocyte differentiation and function, with obvious ramifications for the pathogenesis of central obesit…”
ResultSelf-citationTannin, G. M., Agarwal, A. K., Monder, C., New, M. I., & White, P. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55351-5 · Cited by 436
Brown, R. W., Chapman, K. E., Edwards, C. R., & Seckl, J. R. (1993) · Endocrinology · doi:10.1210/endo.132.6.8504762 · Cited by 271
Cited by
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969
Self-citation11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
11β-Hydroxysteroid Dehydrogenase
Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 718
Self-citationEndocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Murphy, V. E., Smith, R., Giles, W. B., & Clifton, V. L. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0011 · Cited by 671
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-642-19683-6 · Cited by 496
Slominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
Self-citationIshimoto, H., & Jaffe, R. B. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0001 · Cited by 379
11β-Hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action
Draper, N., & Stewart, P. M. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06019 · Cited by 375
Self-citationBujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254
Self-citationGlucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239
“However, 11 -HSD1 is widely expressed in other tissues in humans (Ricketts et al., 1998) and rodents (Moisan et al., 1990b), including liver (Agarwal et al., 1989; Tannin et al., 1990), adipose tissue (Bujalska et al., 1997; Napolitano et al., 1998), lung (Hundertmark et al., 1993), skeletal…”
Kannisto, K., Pietiläinen, K. H., Ehrenborg, E., Rissanen, A., Kaprio, J., Hamsten, A., & Yki-Järvinen, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0153 · Cited by 205
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
Self-citationBujalska, I. J., Draper, N., Michailidou, Z., Tomlinson, J. W., White, P. C., Chapman, K. E., Walker, E. A., & Stewart, P. M. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01718 · Cited by 165
Self-citationDiederich, S., Eigendorff, E., Burkhardt, P., Quinkler, M., Bumke-Vogt, C., Rochel, M., Seidelmann, D., Esperling, P., Oelkers, W., & Bähr, V. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020970 · Cited by 154
Swart, A. C., Schloms, L., Storbeck, K.-H., Bloem, L. M., Toit, T. D., Quanson, J. L., Rainey, W. E., & Swart, P. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.010 · Cited by 125
Self-citationTiganescu, A., Walker, E. A., Hardy, R. S., Mayes, A. E., & Stewart, P. M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.257 · Cited by 122
A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease
Ahmed, A., Rabbitt, E., Brady, T., Brown, C., Guest, P., Bujalska, I. J., Doig, C., Newsome, P. N., Hubscher, S., Elias, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029531 · Cited by 115
“After washing in phosphate buffered saline (PBS) sections were incubated in 20% normal donkey serum for 30 minutes and then with polyclonal antibody to 11b-HSD1 [20] at a dilution of 1 in 100 in 10% donkey serum for 45 minutes.”
MethodSelf-citationSkobowiat, C., Sayre, R. M., Dowdy, J. C., & Slominski, A. T. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12096 · Cited by 115
Cai, T.-Q., Wong, B., Mundt, S. S., Thieringer, R., Wright, S. D., & Hermanowski-Vosatka, A. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00041-3 · Cited by 98
Giavoli, C., Libé, R., Corbetta, S., Ferrante, E., Lania, A., Arosio, M., Spada, A., & Beck-Peccoz, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1114 · Cited by 97
Hennebert, O., Chalbot, S., Alran, S., & Morfin, R. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.03.026 · Cited by 79
Evidence That the 11 β-Hydroxysteroid Dehydrogenase (11 β-HSD1) Is Regulated by Pentose Pathway Flux
McCormick, K. L., Wang, X., & Mick, G. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506026200 · Cited by 72
Walker, E. A., Clark, A. M., Hewison, M., Ride, J. P., & Stewart, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011142200 · Cited by 65
Self-citationImpact of the GH-cortisol ratio on the age-dependent changes in body composition
Nass, R., & Thorner, M. O. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00022-9 · Cited by 58
Serum cortisol/cortisone ratio after Synacthen stimulation
Vogeser, M., Zachoval, R., & Jacob, K. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00251-x · Cited by 37
Coulter, C. L., Smith, R. E., Stowasser, M., Sasano, H., Krozowski, Z. S., & Gordon, R. D. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00077-5 · Cited by 27
Metadata
- Authors
- Ricketts, M. L., Verhaeg, J. M., Bujalska, I., Howie, A. J., Rainey, W. E., & Stewart, P. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1998-04-01
- Volume
- 83
- Issue
- 4
- Pages
- 1325-1335
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1970175977
- Cited by
- 197
- References
- 4
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.